Sphera Funds Management Ltd. X4 Pharmaceuticals, Inc Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$6.09 - $9.15 $3.45 Million - $5.18 Million	-565,804 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$7.98 - $10.44 $2.45 Million - $3.21 Million	-307,411 Reduced 35.2%	565,804 $5.27 Million
Q1 2020 May 14, 2020	BUY	$6.03 - $11.01 $923,886 - $1.69 Million	153,215 Added 21.28%	873,215 $8.73 Million
Q4 2019 Feb 13, 2020	BUY	$9.93 - $14.33 $6.68 Million - $9.64 Million	672,609 Added 1419.28%	720,000 $7.7 Million
Q2 2019 Aug 14, 2019	BUY	$12.57 - $21.67 $595,704 - $1.03 Million	47,391 New	47,391 $0

106

103M

206K

291K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $37.1M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.